Dr Sarah Doffman
MB ChB, FRCP
Having trained in London, Dr Sarah Doffman carried out research into the early diagnosis of invasive fungal pneumonia at St Bartholomew’s and Queen Mary, University of London and worked at the Royal Free Hospital, University College Hospital and Barts and the London Hospitals.
Her specialist interests include lung cancer, tuberculosis and respiratory disease in the immune-compromised host (HIV infection/post-chemotherapy or transplant).
Dr Doffman leads for TB and lung cancer in the Trust and is Chair of the Sussex Cancer Network Lung Tumour Group. She has led two large projects funded by the Department of Health with National Cancer Survivorship Initiative into improving pathways of care and wellbeing in patients living with lung cancer.
She is also a member of the Specialist Advisory Group of the British Thoracic Society for Tuberculosis and the Multi-Drug Resistant Advisory Network, involved in national policy and education.
Dr Sarah Doffman leads the Surrey and Sussex Specialist Respiratory Group Research Network (National Institute for Health Research) improving uptake to clinical trials in respiratory disease across the region. She is lead investigator of a number of trials at BSUH NHS Trust including a study of lung disease in HIV and a large multicentre trial in lung cancer diagnosis.
Some of the principal treatments carried out by Dr Sarah Doffman at Spire include:
Member of the Tuberculosis Specialist Advisory Group of the British Thoracic Society
Chair of the Sussex Cancer Network Lung Tumour Group
Local lead of the Surrey and Sussex Comprehensive Local Research
Network, National Institute for Health Research
Member of the British Thoracic Society
Fellow of the Royal College of Physicians, London
Member of the British Medical Association
Consultant in Respiratory and General Internal Medicine. Brighton and Sussex University Hospitals NHS Trust